Why Quest Diagnostics Inc’s (DGX) Stock Is Down 4.34%
As of Tuesday, July 23, Quest Diagnostics Inc’s DGX share price has dipped by 4.34%, which has investors questioning if this is right time to buy.Jack Gilleland
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
Cynthia McLaughlin
Jenna Brashear
Jack Gilleland
Jenna Brashear
| Share Statistics | DGX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $28,570.9 | $1,570.8 | 89% |
|
| Shares Out (Mil) | 112.0 | 80.2 | 64% |
|
| Institutional Ownership | 99.6% | 88.7% | 90% |
|
| Float (Mil) | 109.4 | 58.4 | 62% |
|
| Beta | 0.54 | 0.77 | 30% |
|
| Avg Daily Volume (000s) | 889 | 655 | 67% |
|
| Price Change (52-week) |
39.5% | 76.0% | 81% |
|
| Growth | DGX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 3.2% | 10.4% | 29% |
|
| Net Income (5yr) | (7.1%) | (0.3%) | 32% |
|
| EPS (5yr) | (3.5%) | 3.0% | 27 |
|
| Dividends (5yr) | 7.4% | 0.0% | 95% |
|
| Cash Flow (5yr) | (35.9%) | (17.5%) | 15% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 13 | 16 | 16 | |
| Current EPS | $2.682 | $11.317 | $11.984 | |
| Month Ago EPS | $2.682 | $11.195 | $12.033 | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | $2.679 | $11.192 | $12.058 | |
| Year/Year Chg | (3.5%) | 29.3% | 48.6% | |
| Financials | DGX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $11,841 | $1,505 | 85% |
|
| Net Income (TTM) (Mil) | $1,129 | $30 | 87% |
|
| EPS (TTM) | $10.274 | $0.300 | 94% |
|
| Operating Cash Flow (TTM) (Mil) | $1,951 | $170 | 88% |
|
| Net Cash Flow (TTM) (Mil) | $365 | $7 | 89% |
|
| Long-Term Debt (Q1) (Mil) | $6,206 | $416 | 87% |
|
| Enterprise Value (Q1) (Mil) | $34,560 | $2,396 | 89% |
|
| Valuation | DGX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.74 | 2.76 | 75% |
|
| P/E | 25.9 | 26.2 | 67% |
|
| Dividend Yield | 1.3% | 0.0% | 69% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | DGX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 33.2% | 27.9% | 40% |
|
| Net Margin | 9.5% | 1.3% | 60% |
|
| ROA | 6.8% | 2.4% | 78% |
|
| ROE | 15.2% | 7.4% | 71% |
|
| Liabilities to Assets | 53.4% | 61.9% | 46% |
|
| F-Score | 7 | 5 | 82% |
|
Quest Diagnostics Incorporated did not pass any screens on 11/18/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors